Skip to main content
OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
1.400
-0.040 (-2.78%)
At close: Apr 28, 2026, 4:00 PM EDT
1.380
-0.020 (-1.43%)
Pre-market: Apr 29, 2026, 7:00 AM EDT

OmniAb Revenue

In the year 2025, OmniAb had annual revenue of $18.67M, down -29.27%. OmniAb had revenue of $8.38M in the quarter ending December 31, 2025, a decrease of -22.47%.

Revenue (ttm)
$18.67M
Revenue Growth
-29.27%
P/S Ratio
10.86
Revenue / Employee
$209,730
Employees
89
Market Cap
202.70M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202518.67M-7.73M-29.27%
Dec 31, 202426.39M-7.77M-22.75%
Dec 31, 202334.16M-24.91M-42.17%
Dec 31, 202259.08M24.33M70.02%
Dec 31, 202134.75M11.48M49.34%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Keros Therapeutics 244.06M
MacroGenics 149.50M
Voyager Therapeutics 40.37M
MediWound 16.96M
Caribou Biosciences 11.16M
Revenue Rankings

OABI News

More News